---
$id: https://graph.org.ai/products/commodity/51171941
$type: Product
source: UNSPSC
code: "51171941"
title: "Metiamide"
class: "51171900"
classTitle: "Antiulcer and related gastrointestinal GI drugs"
family: "51170000"
familyTitle: "Drugs affecting the gastrointestinal system"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Metiamide

**UNSPSC Code**: 51171941
**Class**: [Antiulcer and related gastrointestinal GI drugs](Antiulcer and related gastrointestinal GI drugs.mdx)
**Family**: [Drugs affecting the gastrointestinal system](../Drugs affecting the gastrointestinal system.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a histamine-2 receptor antagonist with the molecular formula C9H16N4S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3K7670861M, chemically known as urea, 1-methyl-3-(2-(((5-methylimidazol-4-yl)methyl)thio)ethyl)-2-thio- but generally known as metiamide, which bears US NIH Compound Identifier 1548992. European Medicines Agency schedules Metiamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08881MIG. The term METIAMIDE is an International Non-Proprietary Name. METIAMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule metiamide under HS 29332990 and SITC 51573. As of Q4 2014, METIAMIDE remains the US FDA Preferred Term for this commodity. Metiamide bears US NLM identifiers UMLS ID C0025845 and NCI Concept Code C90862. SMILES: S(CC1NC[NH]C1C)CCNC(=S)NC.

